Form D Explorer

Inspect source fieldsReport a record issue

Form D — NBO Pharma Inc.

0002103906-26-000001 · filed Jan 22, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(c)
Reported offering amount
$7,640,217
Reported amount sold
$7,640,217
Minimum investment
$10,000
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
NBO Pharma Inc.
CIK
2103906
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2021
Address
64 QUARRY LANE
BEDFORD, New York 10506
Phone
914-645-1130

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗